Stock Fundamentals

Company Information

Company Name
Procept Biorobotics Corp
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US74276L1052
CIK: 0001588978
CUSIP: 74276L105
Currency: USD
Full Time Employees: 756
Phone: 650 232 7200
Fiscal Year End: December
IPO Date: Sep 15, 2021
Description:

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Address:

150 Baytech Drive, San Jose, CA, United States, 95134

Directors & Officers

Name Title Year Born
Mr. Larry L. Wood President, CEO & Director 1966
Mr. Kevin Waters Executive VP & CFO 1977
Ms. Alaleh Nouri EVP, Chief Legal Officer & Corporate Secretary 1979
Mr. Christofer Christoforou Senior Vice President of Operations 1970
Mr. Barry Templin Executive VP & CTO NA
Mr. Matthew James Bacso C.F.A. Vice President of Investor Relations NA
Ms. Stacey L. Porter Chief People Officer 1976
Mr. Bijesh Chandran Senior Vice President of Regulatory Affairs & Quality Assurance NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Eagle Health Investments LP 308.43K Dec 31, 2025 0.55% $2.13 0.00%

Shares Statistics

Shares Outstanding: 55.88M
Shares Float: 54.81M
% Insiders: 445.80%
% Institutions: 10,465.70%
Short % Float: 14.83%

🏆 Top 10 Institutional Holders

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Eagle Health Investments LP 308.43K 0.55% ▲ 0.00% Dec 31, 2025

Valuation Metrics

Enterprise Value: $1.05B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $1.27B
EBITDA: $-97.62M
Book Value: $6.53
Earnings/Share: $-1.53
Profit Margin: -31.02%
Operating Margin: -40.64%
ROA (TTM): -12.46%
ROE (TTM): -24.89%
Revenue (TTM): $308.05M
Revenue/Share (TTM): $5.55
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 11.90%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios (Yearly)

Financial Ratios (Quarterly)

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 6.85x 0.00x 0.28x -11.69x 0.00x
2024-12-31 9.07x 0.13x 0.25x -23.09x -0.65x
2023-12-31 7.63x 0.19x 0.31x -27.33x -0.54x
2022-12-31 7.73x 0.27x 0.36x -15.57x -0.67x
2021-12-31 20.08x 0.20x 0.21x -9.32x -1.03x
2020-12-31 7.57x 0.83x 0.52x -9.09x -1.13x
2019-12-31 7.42x 0.90x 0.53x -60.15x -0.66x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jun 12, 2025 Antal Rohit Desai N/A Sale 25.00K $61.49 $1.54M
Jun 10, 2025 Antal Rohit Desai N/A Sale 25.00K $63.91 $1.60M
Jun 05, 2025 Antal Rohit Desai N/A Sale 25.00K $64.79 $1.62M
Jun 03, 2025 Antal Rohit Desai N/A Sale 25.00K $60.66 $1.52M
Mar 18, 2025 Hisham Shiblaq N/A Sale 247.00 $57.06 $14.09K
Mar 18, 2025 Kevin Waters N/A Sale 733.00 $57.06 $41.82K
Mar 18, 2025 Reza Zadno N/A Sale 5.48K $57.06 $312.40K

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PRCT.US!